174 related articles for article (PubMed ID: 26140473)
1. Reduction in asymmetric dimethylarginine plasma levels by coenzyme Q10 supplementation in patients with type 2 diabetes mellitus.
Hosseinzadeh-Attar M; Kolahdouz Mohammadi R; Eshraghian M; Nakhjavani M; Khorrami E; Ebadi M; Esteghamati A
Minerva Endocrinol; 2015 Dec; 40(4):259-66. PubMed ID: 26140473
[TBL] [Abstract][Full Text] [Related]
2. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus.
Eriksson JG; Forsén TJ; Mortensen SA; Rohde M
Biofactors; 1999; 9(2-4):315-8. PubMed ID: 10416046
[TBL] [Abstract][Full Text] [Related]
3. The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome.
Raygan F; Rezavandi Z; Dadkhah Tehrani S; Farrokhian A; Asemi Z
Eur J Nutr; 2016 Dec; 55(8):2357-2364. PubMed ID: 26385228
[TBL] [Abstract][Full Text] [Related]
4. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial.
Yen CH; Chu YJ; Lee BJ; Lin YC; Lin PT
Br J Nutr; 2018 Jul; 120(1):57-63. PubMed ID: 29936921
[TBL] [Abstract][Full Text] [Related]
5. Asymmetric dimethylarginine and soluble inter-cellular adhesion molecule-1 serum levels alteration following ginger supplementation in patients with type 2 diabetes: a randomized double-blind, placebo-controlled clinical trial.
Zarezadeh M; Saedisomeolia A; Khorshidi M; Kord Varkane H; Makhdoomi Arzati M; Abdollahi M; Yekaninejad MS; Hashemi R; Effatpanah M; Mohammadzadeh Honarvar N
J Complement Integr Med; 2018 Aug; 16(2):. PubMed ID: 30099412
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients.
Fallah M; Askari G; Soleimani A; Feizi A; Asemi Z
Int Urol Nephrol; 2018 Nov; 50(11):2073-2079. PubMed ID: 30251010
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial.
Gholnari T; Aghadavod E; Soleimani A; Hamidi GA; Sharifi N; Asemi Z
J Am Coll Nutr; 2018; 37(3):188-193. PubMed ID: 29111905
[TBL] [Abstract][Full Text] [Related]
8. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.
Hodgson JM; Watts GF; Playford DA; Burke V; Croft KD
Eur J Clin Nutr; 2002 Nov; 56(11):1137-42. PubMed ID: 12428181
[TBL] [Abstract][Full Text] [Related]
9. Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients.
Miyake Y; Shouzu A; Nishikawa M; Yonemoto T; Shimizu H; Omoto S; Hayakawa T; Inada M
Arzneimittelforschung; 1999 Apr; 49(4):324-9. PubMed ID: 10337451
[TBL] [Abstract][Full Text] [Related]
10. Effects of coenzyme Q10 supplementation on serum values of adiponectin, leptin, 8-isoprostane and malondialdehyde in women with type 2 diabetes.
Gholami M; Zarei P; Sadeghi Sedeh B; Rafiei F; Khosrowbeygi A
Gynecol Endocrinol; 2018 Dec; 34(12):1059-1063. PubMed ID: 29933718
[TBL] [Abstract][Full Text] [Related]
11. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W
J Clin Lipidol; 2018; 12(2):417-427.e5. PubMed ID: 29454678
[TBL] [Abstract][Full Text] [Related]
12. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial.
Sanoobar M; Eghtesadi S; Azimi A; Khalili M; Khodadadi B; Jazayeri S; Gohari MR; Aryaeian N
Nutr Neurosci; 2015 May; 18(4):169-76. PubMed ID: 24621064
[TBL] [Abstract][Full Text] [Related]
13. Coenzyme Q10 does not improve peripheral insulin sensitivity in statin-treated men and women: the LIFESTAT study.
Kuhlman AB; Morville T; Dohlmann TL; Hansen M; Kelly B; Helge JW; Dela F
Appl Physiol Nutr Metab; 2019 May; 44(5):485-492. PubMed ID: 30273493
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy.
Päivä H; Lehtimäki T; Laakso J; Ruokonen I; Rantalaiho V; Wirta O; Pasternack A; Laaksonen R
Metabolism; 2003 Mar; 52(3):303-7. PubMed ID: 12647267
[TBL] [Abstract][Full Text] [Related]
15. Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study.
Chang JW; Lee EK; Kim TH; Min WK; Chun S; Lee KU; Kim SB; Park JS
Am J Nephrol; 2007; 27(1):70-4. PubMed ID: 17259696
[TBL] [Abstract][Full Text] [Related]
16. Effects of Coenzyme Q10 Supplementation on Serum Values of Gamma-glutamyl transferase, Pseudocholinesterase, Bilirubin, Ferritin, and High-Sensitivity C-Reactive Protein in Women with Type 2 Diabetes.
Gholami M; Rezvanfar MR; Delavar M; Abdollahi M; Khosrowbeygi A
Exp Clin Endocrinol Diabetes; 2019 May; 127(5):311-319. PubMed ID: 29365333
[TBL] [Abstract][Full Text] [Related]
17. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.
Suksomboon N; Poolsup N; Juanak N
J Clin Pharm Ther; 2015 Aug; 40(4):413-8. PubMed ID: 25913756
[TBL] [Abstract][Full Text] [Related]
18. An assessment of correlation between serum asymmetric dimethylarginine and glycated haemoglobin in patients with type 2 diabetes mellitus.
Začiragić A; Huskić J; Mulabegović N; Avdagić N; Valjevac A; Hasić S; Jadrić R
Bosn J Basic Med Sci; 2014 Feb; 14(1):21-4. PubMed ID: 24579966
[TBL] [Abstract][Full Text] [Related]
19. Coenzyme Q10 and oxidative stress, the association with peripheral sensory neuropathy and cardiovascular disease in type 2 diabetes mellitus.
Forsberg E; Xu C; Grünler J; Frostegård J; Tekle M; Brismar K; Kärvestedt L
J Diabetes Complications; 2015; 29(8):1152-8. PubMed ID: 26395643
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethylarginine and long-term adverse cardiovascular events in patients with type 2 diabetes: relation with the glycemic control.
Hsu CP; Hsu PF; Chung MY; Lin SJ; Lu TM
Cardiovasc Diabetol; 2014 Dec; 13():156. PubMed ID: 25467091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
